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To the Editor: We read with great interest the recently
published paper by Schmidt et al., who prospectively
investigated the association between leptin levels and
incident diabetes in middle-aged adults in the Atheroscle-
rosis Risk in Communities (ARIC) study [1]. We were
intrigued by their results, which showed that high leptin
levels predicted a lower risk of type 2 diabetes, once
adjusted for factors purportedly associated with leptin
resistance. Their results prompted us to perform similar
analyses in the Hoorn Study. In this letter we would like to
share our results, but also express some caution regarding
the interpretation of the results.
The Hoorn Study is a population-based cohort study of
glucose tolerance, which started in 1989 and included 2,484
white men and women aged 50 to 75 years [2]. An
extensive physical examination took place and leptin was
measured by means of a radioimmunoassay [3]. From 1996
to 1998 follow-up examinations were conducted [4]. Of the
remaining 2,086 subjects who were invited, 1,513 subjects
(72.5%) participated. After exclusion of subjects with type
2 diabetes at baseline and of subjects with missing data on
leptin or covariates, prospective analyses were performed in
1,238 subjects (573 men and 665 women). The presence of
type 2 diabetes at follow-up was ascertained by an OGTT,
and defined according to the WHO 1999 criteria [5]. In
addition, to make the study more comparable to the ARIC
study, analyses were also performed using the diabetes
definition according to the American Diabetes Association
(ADA) 1997 criteria [6], which is based on fasting glucose
levels only (86% of the cases were diagnosed on the basis
of fasting glucose in the ARIC study [1]). Informed consent
was obtained from all participants and ethical approval for
the study was obtained from the local ethics committee.
The mean age at baseline was 60.1±6.9 years (60.0±
6.9 years in men and 60.2±6.8 years in women), and
median (interquartile range) leptin concentrations were 7.04
(2.99–15.16) μg/l (3.05 [1.66–5.34] μg/l in men, 13.68
[8.13–22.85] μg/l in women). After a mean follow-up of
6.4 years, 59 men and 57 women had developed type 2
diabetes according to the WHO 1999 criteria, and 51 men
and 47 women had developed the disease according to the
ADA 1997 criteria. Table 1 shows the results of logistic
regression analyses, in which odds ratios for developing
type 2 diabetes according to ADA 1997 are calculated. In
women, but not in men, a positive statistically significant
association was shown between leptin and incident diabe-
tes, after adjustment for age (model 1). After adjustment for
BMI, the difference between men and women disappeared
and no association was observed in either sex (model 2). To
study the individual influence of WHR and metabolic
variables on the associations, we adjusted this model for
these factors one by one (models 3 to 8). Finally, we added
all variables to form one regression model, similarly to the
approach of Schmidt et al. (model 9). In contrast to the
results of Schmidt et al., the negative associations were not
statistically significant and appeared more markedly in
men, not in women.
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Table 2 shows the results of logistic regression analyses
when incident diabetes was defined according to the WHO
1999 criteria. After adjustment for age, a significant
positive association between leptin and incident diabetes
was shown, particularly in women. Again, BMI largely
explained this association. In the fully adjusted model,
Table 2 Risk, for sex-specific tertiles of leptin, of developing type 2 diabetes according to the WHO 1999 criteria
2nd tertile 3rd tertile p value for trend
OR 95% CI OR 95% CI
Men
Model 1: age 1.34 0.67–2.66 1.37 0.69–2.71 0.122
Model 2: age + BMI 1.36 0.67–2.75 1.42 0.64–3.17 0.112
Model 3: age + BMI + WHR 1.18 0.58–2.41 1.11 0.49–2.53 0.385
Model 4: age + BMI + ln-insulin 1.26 0.62–2.57 1.13 0.49–2.58 0.327
Model 5: age + BMI + hypertension 1.31 0.65–2.67 1.32 0.59–2.97 0.207
Model 6: age + BMI + ln-triacylglycerol 1.20 0.59–2.46 1.18 0.52–2.68 0.171
Model 7: age + BMI + adiponectin 1.33 0.66–2.69 1.38 0.62–3.08 0.119
Model 8: age + BMI + fasting glucose 1.17 0.55–2.53 1.18 0.51–2.75 0.153
Model 9: all previous 0.99 0.45–2.16 0.77 0.31–1.89 0.659
Women
Model 1: age 1.42 0.64–3.14 2.63 1.27–5.44 0.010
Model 2: age + BMI 1.10 0.48–2.51 1.50 0.64–3.56 0.460
Model 3: age + BMI + WHR 0.92 0.40–2.13 1.30 0.54–3.14 0.484
Model 4: age + BMI + ln-insulin 1.06 0.46–2.41 1.32 0.55–3.20 0.725
Model 5: age + BMI + hypertension 1.09 0.48–2.49 1.46 0.61–3.48 0.602
Model 6: age + BMI + ln-triacylglycerol 0.91 0.39–2.12 1.28 0.54–3.06 0.465
Model 7: age + BMI + adiponectin 0.97 0.42–2.23 1.28 0.53–3.11 0.999
Model 8: age + BMI + fasting glucose 1.28 0.54–3.03 1.49 0.58–3.82 0.612
Model 9: all previous 0.94 0.38–2.32 1.20 0.45–3.19 0.864
The first leptin tertile is the reference category. Values are odds ratios (ORs) with 95% CIs.
Table 1 Risk, for sex-specific tertiles of leptin, of developing type 2 diabetes according to the ADA 1997 criteria
2nd tertile 3rd tertile p value for trend
OR 95% CI OR 95% CI
Men
Model 1: age 1.06 0.52–2.17 1.11 0.55–2.26 0.101
Model 2: age + BMI 1.07 0.51–2.23 1.12 0.48–2.60 0.076
Model 3: age + BMI + WHR 0.91 0.43–1.92 0.85 0.36–2.01 0.287
Model 4: age + BMI + ln-insulin 0.99 0.47–2.09 0.90 0.38–2.14 0.202
Model 5: age + BMI + hypertension 1.04 0.50–2.18 1.06 0.45–2.46 0.124
Model 6: age + BMI + ln-triacylglycerol 0.93 0.44–1.96 0.91 0.39–2.15 0.110
Model 7: age + BMI + adiponectin 1.04 0.50–2.17 1.08 0.47–2.50 0.078
Model 8: age + BMI + fasting glucose 0.84 0.37–1.91 0.90 0.37–2.19 0.088
Model 9: all previous 0.69 0.30–1.61 0.59 0.23–1.55 0.304
Women
Model 1: age 1.04 0.45–2.43 2.05 0.97–4.35 0.025
Model 2: age + BMI 0.80 0.34–1.93 1.14 0.46–2.83 0.541
Model 3: age + BMI + WHR 0.65 0.27–1.58 0.94 0.37–2.41 0.582
Model 4: age + BMI + ln-insulin 0.78 0.32–1.87 1.03 0.41–2.60 0.741
Model 5: age + BMI + hypertension 0.79 0.33–1.91 1.10 0.44–2.74 0.724
Model 6: age + BMI + ln-triacylglycerol 0.67 0.27–1.63 0.98 0.39–2.43 0.547
Model 7: age + BMI + adiponectin 0.73 0.30–1.76 1.01 0.40–2.54 0.939
Model 8: age + BMI + fasting glucose 0.93 0.37–2.36 1.11 0.40–3.05 0.702
Model 9: all previous 0.71 0.27–1.89 0.93 0.32–2.66 0.835
The first leptin tertile is the reference category. Values are odds ratios (ORs) with 95% CIs.
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higher leptin levels were associated with a slightly lower
risk of type 2 diabetes in men, but not in women.
In the Hoorn Study, therefore, we were able to
replicate—in men, but not in women—the findings of
Schmidt et al. from the ARIC Study, when type 2 diabetes
was defined on the basis of fasting glucose levels only.
However, if incident type 2 diabetes was defined according
to the WHO 1999 criteria, which also includes post-load
glucose levels and is considered the gold standard for
diagnosis of type 2 diabetes, there was no longer a strong
negative association in men.
Schmidt et al. discuss the possibility of over-adjustment
when adjusting for baseline glucose levels, because glucose
may mediate part of the association, while other variables are
considered to be true confounders. We argue, however, that
controlling for other metabolic factors may also result in over-
adjustment, because they also may well be mediators in the
causal pathway by which high leptin leads to type 2 diabetes.
The interpretation of the regression model that includes all
these factors implies that a person with high leptin per BMI
who does not develop insulin resistance, hypertension and
metabolic abnormalities has advantages with respect to
diabetes risk. It should, however, be realised that unfortunate-
ly most obese people do in fact develop these adiposity-
related abnormalities. In addition, the results of the Hoorn
Study, using data from the OGTT, suggest that the seemingly
beneficial effect of high leptin after adjustment could also be
an artefact due to imprecise measurement of diabetes.
In conclusion, we were not able to confirm the negative
associations between leptin and incident diabetes when
diabetes diagnosis was based on both fasting and post-load
glucose levels (gold standard), and after adjusting for
measures of obesity and metabolic factors. Although a
weak negative association in men cannot be excluded, the
adjustments for obesity and metabolic factors probably
represent over-adjustment as a result of adjusting for
mediating factors.
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